What does Acurx Pharmaceuticals, Inc. do?
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat…
What is Acurx Pharmaceuticals, Inc.'s P/E and P/B ratio?
Acurx Pharmaceuticals, Inc. has a P/E ratio of -0.4 and a P/B ratio of 0.78.
What is Acurx Pharmaceuticals, Inc.'s debt-to-equity ratio?
Acurx Pharmaceuticals, Inc. has a debt-to-equity ratio of 0.00.
How much does Acurx Pharmaceuticals, Inc. owe compared with what it owns?
Acurx Pharmaceuticals, Inc. owes $0.26 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Acurx Pharmaceuticals, Inc.'s Positivity rank?
Acurx Pharmaceuticals, Inc. is ranked #1,314 of 6,774 companies globally and #275 of 4,000 in United States on PositoAI, with a Positivity Score of 22,947.
Does Acurx Pharmaceuticals, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Acurx Pharmaceuticals, Inc..
Where can I read the latest news about Acurx Pharmaceuticals, Inc.?
Recent headlines about Acurx Pharmaceuticals, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Acurx Pharmaceuticals, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Acurx Pharmaceuticals, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.